Target intelligence / Profile preview

TATA-box-binding protein-associated factor 11-like protein 13 (TAF11L13)

Target
TAF11L13
Molecular classification
Transcription factor, General transcription factor complex component (predicted), TFIID subunit (predicted)
01

Overview

TAF11L13 (TATA-box-binding protein-associated factor 11-like protein 13) is a protein predicted to function as a component of the transcription factor IID (TFIID) complex in the nucleus, which is involved in the initiation of transcription by RNA polymerase II[2]. This protein is predicted to contribute to the assembly of the RNA polymerase II preinitiation complex and shows protein heterodimerization activity, which is a feature shared with recognized TFIID subunits such as TAF11 and TAF13[2]. TAF11L13 parallels other TAF11-like proteins in sequence and domain structure, but its specific role, subunit interactions, and functional significance are largely uncharacterized. There are no experimental or clinical data indicating that TAF11L13 is a therapeutic target or that it has known roles in disease, drug interactions, or biomarker applications at present[2]. Key notes: - TAF11L13 is inferred by genomics and sequence homology; there is no published evidence it encodes a functional protein or protein complex in humans or any model organism[2]. - Most references describing the functional biology pertain to TAF11 and TAF13—canonical, well-characterized TFIID subunits—but not TAF11L13[1][2][3][4][7]. - The use of "TAF11L13" as a unique protein or drug target is unsupported by primary literature; it appears to be a computational designation or predicted gene with little or no experimental validation[2]. - There is no data supporting a direct role in disease, or listing of small-molecule or biological drug modulators[2]. Summary: TAF11L13 is a predicted gene/protein of unclear function and is not recognized as a therapeutic target. Its name derives from homology to TFIID subunits TAF11 and TAF13, which are bona fide components of the general transcription machinery, but there is no evidence that TAF11L13 fulfills a discrete molecular or physiological role, is druggable, or is involved in any disease process[2]. This entry should be regarded as potentially incorrect or at least currently unsupported as a therapeutic target.

Other names
TAF11L13TATA-box binding protein associated factor 11 like 13TATA-box-binding protein-associated factor 11-like protein 13
02

Biological functions

Transcription initiation (RNA polymerase II)Preinitiation complex assemblyProtein heterodimerization

Beyond the preview

Go deeper on TATA-box-binding protein-associated factor 11-like protein 13 (TAF11L13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TATA-box-binding protein-associated factor 11-like protein 13 (TAF11L13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call